article thumbnail

A New Look Representing the Importance of Quality Medication Use

PQA

This is the first major update to PQA’s look since the organization was established in 2006. Our name, our mission and our identity remain unchanged, and we continue to evolve from a position of strength.

article thumbnail

Can a nasal spray tackle agitation in autism?

Pharmaceutical Technology

Dr Jeremy Veenstra-VanderWeele, professor of developmental neuropsychiatry at the Columbia University Irving Medical Center, explains that agitation is seen in the minority of autistic teens, who struggle with communication. An inability to clearly communicate with others and express their wants and needs results in frustration, he adds.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS Pharmaceutical Strategy for Europe. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006.

article thumbnail

Rare Disease Day and a Focus on Quality

PQA

If you have questions or would like to be involved, email us at Communications@PQAalliance.org. __ About PQA and PQA Convenes PQA is a national quality organization dedicated to improving medication safety, adherence and appropriate use.

article thumbnail

From the Porcine to the Ridiculous: Veterinary Drugmaker Sues FDA for Alleged APA Violations

The FDA Law Blog

The EU prohibited it in 1999, almost immediately after FDA approved the testing methods at issue here, and Canada banned it in 2006. At that time, the Agency allowed it to stay on the market under a program that tested edible portions of pigs, a method FDA now claims is not sufficient.

FDA 59
article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

The FDA Law Blog

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.

article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

He joined Johnson & Johnson in 2001 as Director Corporate Communications. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. In that function, he initially worked in the field of oncology.